Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diluted Verapamil vs Nicardipine for Discomfort in Transradial Access
NCT05625503Phase 1Completed
- Sponsor
- University of Illinois Chicago
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of verapamil in Peripheral vasospasm (2 arms), sponsored by University of Illinois Chicago. Primary endpoints: Radial Artery Spasm at 30 minutes, Pain Prior to Intra-arterial Calcium Channel Blocker Administration and 1 more. Started Dec 2022; status: completed.
02
Drugs
verapamil
03
Conditions
Peripheral vasospasm
Beyond the preview
Go deeper on NCT05625503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05625503.